190
Views
33
CrossRef citations to date
0
Altmetric
CASE REPORT

Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab

, , , , , & show all
Pages 475-478 | Received 05 Oct 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sandra M. Quezada, Leon P. McLean & Raymond K. Cross. (2018) Adverse events in IBD therapy: the 2018 update. Expert Review of Gastroenterology & Hepatology 12:12, pages 1183-1191.
Read now
Leon P McLean & Raymond K Cross. (2014) Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Review of Gastroenterology & Hepatology 8:3, pages 223-240.
Read now
Hayato Yamazaki, Susumu Isogai, Tetsushi Sakurai & Kenji Nagasaka. (2010) A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis. Modern Rheumatology 20:5, pages 518-521.
Read now
Enrique J Calderón, Sonia Gutiérrez-Rivero, Isabelle Durand-Joly & Eduardo Dei-Cas. (2010) Pneumocystis infection in humans: diagnosis and treatment. Expert Review of Anti-infective Therapy 8:6, pages 683-701.
Read now

Articles from other publishers (29)

Dimitris C. Kounatidis, Vasileios Papadimitropoulos, Konstantinos Avramidis, Evgenia Plenga, Ioanna Tsiara, Elena Avgoustou, Natalia Vallianou & Dimitrios Vassilopoulos. (2023) Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review. Rheumatology International.
Crossref
Tania M. Gonzalez Santiago, David A. Wetter, Amer N. Kalaaji, Andrew H. Limper & Julia S. Lehman. (2016) Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis . International Journal of Dermatology 55:8, pages 823-830.
Crossref
Colum Downey. (2016) Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review. International Journal of Rheumatic Diseases 19:6, pages 536-550.
Crossref
Spyros A. Papiris, Effrosyni D. Manali, Likurgos Kolilekas, Konstantinos Kagouridis, Maria Maniati, Gerasimos Filippatos & Demosthenes Bouros. (2016) Acute Respiratory Events in Connective Tissue Disorders. Respiration 91:3, pages 181-201.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 66 71 .
Jiraprapa Wipasa, Panuwat Wongkulab, Kriangkrai Chawansuntati, Romanee Chaiwarit & Khuanchai Supparatpinyo. (2014) Cellular Immune Responses in HIV-Negative Immunodeficiency with Anti-Interferon-γ Antibodies and Opportunistic Intracellular Microorganisms. PLoS ONE 9:10, pages e110276.
Crossref
N. Montserrat Ortiz, P. Gormaz Torres, M. Justes Mateos, G. Bello Rodriguez, E. Vicario Izquierdo & M. León Vallés. (2014) Neumonía grave por Pneumocystis jiroveci en paciente con enfermedad de Crohn y tratamiento con adalimumab. Medicina Intensiva 38:6, pages 397-399.
Crossref
Michael M. Opata, Zhan Ye, Melissa Hollifield & Beth A. Garvy. (2013) B Cell Production of Tumor Necrosis Factor in Response to Pneumocystis murina Infection in Mice. Infection and Immunity 81:11, pages 4252-4260.
Crossref
Guang-Sheng Lei, Chen Zhang, Shoujin Shao, Hsin-Wei Jung, Pamela J. Durant & Chao-Hung Lee. (2013) All-Trans Retinoic Acid in Combination with Primaquine Clears Pneumocystis Infection. PLoS ONE 8:1, pages e53479.
Crossref
Robert P Baughman, Keith C Meyer, Ian Nathanson, Luis Angel, Sangeeta M Bhorade, Kevin M Chan, Daniel Culver, Christopher G Harrod, Mary S Hayney, Kristen B Highland, Andrew H Limper, Herbert Patrick, Charlie Strange & Timothy Whelan. (2012) Monitoring of Nonsteroidal Immunosuppressive Drugs in Patients With Lung Disease and Lung Transplant Recipients. Chest 142:5, pages e1S-e111S.
Crossref
Eva M. Carmona, Theodore J. Kottom, Deanne M. Hebrink, Teng Moua, Raman-Deep Singh, Richard E. Pagano & Andrew H. Limper. (2012) Glycosphingolipids Mediate Pneumocystis Cell Wall β-Glucan Activation of the IL-23/IL-17 Axis in Human Dendritic Cells . American Journal of Respiratory Cell and Molecular Biology 47:1, pages 50-59.
Crossref
Alistair B. Reid, Sharon C.-A. Chen & Leon J. Worth. (2011) Pneumocystis jirovecii pneumonia in non-HIV-infected patients. Current Opinion in Infectious Diseases 24:6, pages 534-544.
Crossref
Robert S. Woodrick & Eric M. Ruderman. (2011) Safety of biologic therapy in rheumatoid arthritis. Nature Reviews Rheumatology 7:11, pages 639-652.
Crossref
Matthew R Gingo, Lorrie Lucht, Kieran R Daly, Kpandja Djawe, Frank J Palella, Alison G Abraham, Jay H Bream, Mallory D Witt, Lawrence A Kingsley, Karen A Norris, Peter D Walzer & Alison Morris. (2011) Serologic Responses to Pneumocystis Proteins in HIV Patients With and Without Pneumocystis jirovecii Pneumonia. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:3, pages 190-196.
Crossref
Eva M. Carmona & Andrew H. Limper. (2010) Update on the diagnosis and treatment of Pneumocystis pneumonia . Therapeutic Advances in Respiratory Disease 5:1, pages 41-59.
Crossref
Hidekazu IKEUCHI, Azusa UMEMOTO, Mayuko TSUKIDA, Noriyuki SAKURAI, Akito MAESHIMA, Takashi KUROIWA, Keiju HIROMURA & Yoshihisa NOJIMA. (2011) Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumabアダリムマブ投与中にニューモシスチス肺炎を発症した関節リウマチ患者2例の報告. Japanese Journal of Clinical Immunology 34:5, pages 420-425.
Crossref
Julia S. Lehman & Amer N. Kalaaji. (2010) Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions. Journal of the American Academy of Dermatology 63:5, pages 815-823.
Crossref
Hayato Yamazaki, Susumu Isogai, Tetsushi Sakurai & Kenji Nagasaka. (2010) A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis. Modern Rheumatology 20:5, pages 518-521.
Crossref
Keith C. Meyer, Catherine Decker & Robert Baughman. (2010) Toxicity and Monitoring of Immunosuppressive Therapy Used in Systemic Autoimmune Diseases. Clinics in Chest Medicine 31:3, pages 565-588.
Crossref
P. Germaud, D. Boutoille & F. Gay-Andrieu. (2010) Mycoses bronchopulmonaires (aspects immunoallergiques exclus). EMC - Pneumologie 7:1, pages 1-26.
Crossref
Felix Braun, Nadja Rifaie, Dieter C. Broering & Matthias Behrend. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 675 704 .
Vasilios Pyrgos, Shmuel Shoham, Emmanuel Roilides & Thomas J. Walsh. (2009) Pneumocystis pneumonia in children. Paediatric Respiratory Reviews 10:4, pages 192-198.
Crossref
Bryan J. Krajicek, Charles F. ThomasJr.Jr. & Andrew H. Limper. (2009) Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment. Clinics in Chest Medicine 30:2, pages 265-278.
Crossref
James C Lee, Deborah C Bell, Richard M Guinness & Tariq Ahmad. (2009) Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFα naive patient with ulcerative colitis. World Journal of Gastroenterology 15:15, pages 1897.
Crossref
Ennio Giulio Favalli, Francesca Desiati, Fabiola Atzeni, Piercarlo Sarzi-Puttini, Roberto Caporali, Francesca Bobbio Pallavicini, Roberto Gorla, Matteo Filippini & Antonio Marchesoni. (2009) Serious infections during anti-TNFα treatment in rheumatoid arthritis patients. Autoimmunity Reviews 8:3, pages 266-273.
Crossref
Michael A. Pfaller & Elias J. Anaissie. 2009. Clinical Mycology. Clinical Mycology 385 401 .
Bryan J Krajicek, Andrew H Limper & Charles F Thomas. (2008) Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia. Current Opinion in Pulmonary Medicine 14:3, pages 228-234.
Crossref
L. Beth Gadkowski & Jason E. Stout. (2008) Cavitary Pulmonary Disease. Clinical Microbiology Reviews 21:2, pages 305-333.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.